By Rebecca Melvin
New York, Feb. 27 – Great Basin Scientific Inc. plans to sell $23.97 million of units, consisting of one share of series E convertible preferred shares and eight series C warrants on a best-efforts basis by Dawson James Securities Inc., according to a prospectus.
The units are being offered at $8.80 each. The units, preferred stock and warrants will separate automatically after six months. There is early separation if shares exceed $4.00 for 20 consecutive trading days. Great Basin’s share reference price is $2.67.
Each convertible preferred share will be convertible into four shares of common stock, and the warrants are exercisable for one share of common stock at an exercise price of $2.55.
About $3.8 million of the proceeds is earmarked for research and development, including regulatory filings, and about $3.2 million is for sales and marketing expenses. Proceeds will also be used to expand manufacturing, to repay outstanding principal of a loan agreement and for general corporate purposes.
The units will be listed on the Nasdaq Capital Markets under the symbol “GBSNU.”
Salt Lake City-based Great Basin is a molecular diagnostic testing company that develops and makes test kits for single pathogen testing. It does business under the name Great Basin Corp.
Issuer: | Great Basin Scientific Inc.
|
Issue: | Units
|
Amount: | $23.97 million
|
Price: | $8.80 each
|
Bookrunner: | Dawson James Securities Inc.
|
Maturity: | After six months, the units consisting of convertible preferred shares and warrants will separate
|
Early separation: | If shares exceed $4.00
|
Convertible preferreds: | Convert into four shares of common stock
|
Warrants: | Exercisable for one share at exercise price of $2.55
|
Pricing date: | Feb. 26
|
Stock symbol: | Nasdaq: GBSN
|
Proposed unit symbol: | Nasdaq: GBSNU
|
Stock reference price: | $2.67 as of close Feb. 26
|
Market capitalization: | $13.33 million
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.